Please confirm email address:

Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression

Endoscopic ablation in patients with Barrett’s esophagus containing confirmed low-grade dysplasia reduces the relative risk for disease progression by 94% as compared to controls

FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice

/PRNewswire/ -- On May 9, 2013, FTI Consulting, Inc. (NYSE: FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value (the "Company"), announced that it has combined the healthcare and life sciences focused personnel that were formerly included within the Corporate Finance/Restructuring segment with those in the Forensic and Litigation Consulting segment to form a single integrated practice whose financial results and other information are reported within the Forensic and Litigation Consulting segment.
BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference

Presentation to be Webcast at 2:30 Eastern Time on May 30, 2013
BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference

Presentation to be Webcast at 2:30 Eastern Time on May 30, 2013
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market

As part of the company’s push to carve out a share of the $142 billion U.S. drug delivery market, Rainbow Coral Corp. (OTCBB: RBCC) opened talks this week to potentially partner with an emerging innovator in the transdermal delivery sector.
BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC™ Stem Cell Therapy Device

Device Plays Integral Role in Delivering Stem Cells for its Proprietary Bulging/Herniated Disc Therapy
Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy

Non-Surgical Procedure Yields High Patient Satisfaction Scores; Reduced Need for Medication; No Serious Adverse Effects
Data on Cook Medical Products Presented at Digestive Disease Week®

At this week’s Digestive Disease Week (DDW), the world’s largest gathering of physicians and researchers in the gastroenterology field, six abstracts and other clinical data will be presented on Cook Medical products. Cook’s EchoTip® ProCore™ High Definition Ultrasound Biopsy needles are featured in many of these presentations.
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy

—Data Presented at AED Xll Meeting Confirms INS001 Appears Safe and Well Tolerated—, —Preparations for Phase II Proof of Principle Trial Underway—,
Santarus Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting

Santarus, Inc. (NASDAQ: SNTS) today announced that additional data from two pivotal clinical studies with UCERIS® (budesonide) extended release tablets will be featured in two poster presentations at the Digestive Disease Week® (DDW®) Meeting being held in Orlando, Fla. from May 18 – 21, 2013.
Stem Cell Action Coalition Applauds Cloned Stem Cell Breakthrough

The Stem Cell Action Coalition, a network of 75 nonprofit disease advocacy groups, scientific societies and academic centers, applauds the researchers at the Oregon Health and Science University for their groundbreaking accomplishment of producing stem cells utilizing the process of somatic cell nuclear transfer (SCNT).
TherapeuticsMD Elects Jules A. Musing to Board of Directors

TherapeuticsMD, Inc. (NYSE MKT: TXMD), a women’s healthcare company focused on developing and commercializing products targeted exclusively for women, today announced the election of Jules A. Musing, a former senior executive at Johnson & Johnson, to its Board of Directors, effective immediately.
Dyadic International Reports First Quarter 2013 Financial Results

-- Signs Landmark Research & License Agreement with BASF (subsequent event) --, -- Enzyme Product Sales Up 20% Y/Y --, -- Cash Balance Up 3% from December 31, 2012 --, -- Expects Revenue Growth and Profitability for Full Year 2013 --, -- Strengthens Manag
Entia hires director of marketing for medical foods and consumer products

Expanded GROH® line to be launched at Intercoiffure America/Canada May 19th & 20th
BASF And Dyadic International Enter Into A Research And License Agreement

Dyadic's C1 Technology Platform Enables BASF to Develop Enzymes for Multiple Market Segments
Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today they will present linaclotide-related data during Digestive Disease Week® 2013 in Orlando, Fla., May 18 through May 21, 2013. Among the data highlighted will be two oral presentations: one providing insight into the GC-C/cGMP pathway in patients with IBS-C and another describing the effects of linaclotide on inhibiting visceral pain, both based on nonclinical studies.
Sucampo Pharmaceuticals to Host Update on AMITIZA® OIC Indication May 20th

Sucampo Pharmaceuticals, Inc. (“Sucampo”) (NASDAQ: SCMP), a global pharmaceutical company, today announced that it will host a meeting to discuss the recent opioid-induced constipation (OIC) indication approval for its flagship product, AMITIZA, on May 20, 2013, from 9:00 to 10:30AM ET in Orlando, FL. Members of Sucampo’s management team and two key outside experts will provide a market update, overview of the scientific data, and clinical perspectives relevant to OIC.
RBCC Partner n3D Signs U.S. Distribution Agreement

Rainbow Coral Corp. (OTCBB: RBCC) received word this week that the revolutionary technology developed by its partner, Nano3D Biosciences (n3D), is set to begin penetrating the U.S. marketplace.
CleanPath Resources Corp Announces Preliminary Research Report on New Stem Cell Enhancement Product NutraLoad™

/PRNewswire/ -- CleanPath Resources Corp (OTC Pink: CLNP) (www.re-load.biz) CleanPath Resources' newest research and development partner, BioSwan, Inc., just announced new research initiatives for its stem cell enhancement product NutraLoad™. The next phase of research will take place in Europe and Asia and will be focused on NutraLoad™'s efficacy on targeted health issues.
TherapeuticsMD Reports First Quarter 2013 Financial Results

TherapeuticsMD, Inc. (NYSE MKT:TXMD), a women’s healthcare company focused on developing and commercializing products targeted exclusively for women, today announced financial results for the three months ended March 31, 2013.

Search: Horoscopes | Comics & Games | Data Sleuth

VIDEO

» More video

Marketplace

Quick Job Search

Covidien Announces Clinical Trial Data Showing Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression

FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice

BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference

BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference

RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market

BioRestorative Therapies Signs Agreement with Dexterity, Inc. to Advance Production of the Company's Novel brtxDISC™ Stem Cell Therapy Device

Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy

Data on Cook Medical Products Presented at Digestive Disease Week®

Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy

Santarus Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting

Stem Cell Action Coalition Applauds Cloned Stem Cell Breakthrough

TherapeuticsMD Elects Jules A. Musing to Board of Directors

Dyadic International Reports First Quarter 2013 Financial Results

Entia hires director of marketing for medical foods and consumer products

BASF And Dyadic International Enter Into A Research And License Agreement

Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013

Sucampo Pharmaceuticals to Host Update on AMITIZA® OIC Indication May 20th

RBCC Partner n3D Signs U.S. Distribution Agreement

CleanPath Resources Corp Announces Preliminary Research Report on New Stem Cell Enhancement Product NutraLoad™

TherapeuticsMD Reports First Quarter 2013 Financial Results

VIDEO

Marketplace

Quick Job Search

Miami Top Jobs

Ad links